Get the Stockscreener App
19.79
0.25%
0.05
After Hours:
19.79
Surgery Partners Inc stock is traded at $19.79, with a volume of 1.17M.
It is up +0.25% in the last 24 hours and down -9.51% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$19.74
Open:
$19.85
24h Volume:
1.17M
Relative Volume:
0.80
Market Cap:
$2.54B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-73.30
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-2.94%
1M Performance:
-9.51%
6M Performance:
-5.72%
1Y Performance:
-35.03%
1-Day Range:
$19.57
$20.16
1-Week Range:
$19.57
$20.77
52-Week Range:
$18.87
$33.37
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
19.79 | 2.53B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
410.68 | 97.14B | 72.70B | 6.88B | 7.29B | 23.81 |
|
THC
Tenet Healthcare Corp
|
190.00 | 16.75B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.41 | 15.74B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
121.31 | 12.30B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
197.76 | 12.48B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
What data driven models say about Surgery Partners Inc.’s future2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Does Surgery Partners Inc. qualify in momentum factor screeningJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Tools to assess Surgery Partners Inc.’s risk profileJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
What analysts say about Surgery Partners Inc stockStock Price Divergence & The Smart Money Is Buying These Picks - earlytimes.in
Using economic indicators to assess Surgery Partners Inc. potentialJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
What’s next for Surgery Partners Inc. stock priceJobs Report & Daily Momentum Trading Reports - newser.com
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Multi factor analysis applied to Surgery Partners Inc.Portfolio Performance Summary & Low Risk Entry Point Guides - newser.com
Surgery Partners jumps on $25.75 a share offer from Bain Capital (update) - MSN
Applying Wyckoff theory to Surgery Partners Inc. stock2025 Market Outlook & Weekly High Momentum Picks - newser.com
Real time breakdown of Surgery Partners Inc. stock performanceEarnings Beat & Low Drawdown Investment Strategies - newser.com
Surgery Partners (NASDAQ:SGRY) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Surgery Partners (SGRY): Assessing Value After Recent Share Price Weakness - Yahoo Finance
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
MAX Surgical Partners With Manhattan Specialists - Dentistry Today
SGRY: Cantor Fitzgerald Reiterates "Overweight" Rating, Price Ta - GuruFocus
Surgery Partners' (SGRY) Overweight Rating Reiterated at Cantor Fitzgerald - MarketBeat
Oversold Conditions For Surgery Partners (SGRY) - Nasdaq
Relative strength of Surgery Partners Inc. in sector analysisJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com
What earnings revisions data tells us about Surgery Partners Inc.July 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Understanding Surgery Partners Inc.’s price movementTrade Volume Report & Daily Entry Point Alerts - newser.com
Is Surgery Partners Inc. a candidate for recovery playTrade Analysis Summary & Real-Time Buy Zone Alerts - newser.com
Bend Surgeon Delivers Wound Care by Air to Rural PatientsThe SourceBend, OregonThe Source - The Source - Bend, Oregon
Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Performance Shifts - Markets Mojo
Surgery Partners Inc Stock Analysis and ForecastRelative Strength Index (RSI) & The Smart Money Is Buying These Picks - earlytimes.in
14,442 Shares in Surgery Partners, Inc. $SGRY Purchased by Camelot Portfolios LLC - MarketBeat
What analysts say about AAC Clyde Space AB publ MKC0 stockMarket Liquidity Analysis & Stocks With 200% Upside Potential - Early Times
Surgery Partners stock rating reiterated as Cantor Fitzgerald sees stable ASC data By Investing.com - Investing.com Nigeria
Surgery Partners stock rating reiterated as Cantor Fitzgerald sees stable ASC data - Investing.com Canada
What indicators show strength in Surgery Partners Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Surgery Partners (NASDAQ:SGRY) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
0.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):